Antimicrobial resistance in Gram-positive pathogens isolated in the UK between October 1996 and January 1997

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 5, 1999, Pages 689-698

  Andrews, J ^a   Ashby, J ^a   Jevons, G ^a   Lines, N ^a   Wise, R ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; METICILLIN; NITROFURANTOIN; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; ELECTRON MICROSCOPY; ENTEROCOCCUS FAECALIS; GRAM POSITIVE BACTERIUM; HUMAN; MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECIUM; ENVIRONMENTAL MONITORING; GRAM-POSITIVE BACTERIA; GREAT BRITAIN; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; VANCOMYCIN; VIRGINIAMYCIN;

EID: 0032921668     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.5.689     Document Type: Article

References (20)

1. Baquero, F. (1995). Pneumococcal resistance to β-lactam antibiotics: a global geographic overview. Microbial Drug Resistance 1, 115-20.
2. Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T. & Braveny, I. (1994). Methicillin-resistant Staphylococcus aureus in Europe. European Journal of Clinical Microbiology and Infectious Diseases 13, 50-5.
3. Kunin, C. M. (1993). Resistance to antimicrobial drugs - a worldwide calamity. Annals of Internal Medicine 118, 557-61.
4. Hiramatsu, K., Hanki, H., Ino, T., Yabuta, K., Oguri, T. & Tenover, F. C. (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Journal of Antimicrobial Chemotherapy 40, 135-6.
5. Centres for Disease Control. (1997). Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR - Morbidity and Mortality Weekly Report 46, 765-6.
6. Bouanchaud, D. H. (1997). In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin. Journal of Antimicrobial Chemotherapy 39, Suppl. A, 15-21.
7. Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 1-50.
8. Anonymous. (1997). Detecting vancomycin intermediate Staphylococcus aureus. Communicable Disease Report CDR Weekly 7, 417, 20.
9. Comité de l'Antibiogramme de la Société Française de Microbiologie. (1996). Clinical Microbiology and Infection 2, Suppl. 1.
10. Gilbart, J., Perry, C. R. & Slocombe, B. (1993). High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrobial Agents and Chemotherapy 37, 32-8.
11. Snell, J. J., Brown, D. F., Perry, S. F. & George, R. (1993). Antimicrobial susceptibility testing of enterococci: results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology. Journal of Antimicrobial Chemotherapy 32, 401-11.
12. National Committee for Clinical Laboratory Standards. (1994). Performance Standards for Antimicrobial Susceptibility Testing - Fifth Informational Supplement M100-S5. NCCLS, Villanova, PA.
13. Stratton, C. W., Gelfand, M. S., Gerberding, J. L. & Chambers, H. F. (1990). Characterization of mechanisms of resistance to β-lactam antibiotics in methicillin-resistant strains of Staphylococcus saprophyticus. Antimicrobial Agents and Chemotherapy 34, 1780-2.
14. Suzuki, E., Hiramatsu, K. & Yokota, T. (1992). Survey of methicillin-resistant clinical strains of coagulase-negative staphylococci for mecA gene distribution. Antimicrobial Agents and Chemotherapy 36, 429-34.
15. Hanaki, M., Kuwahara-Arai, K., Boyle-Vavra, S., Daum, R. S., Labischinski, H. & Hiramatsu, K. (1998). Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. Journal of Antimicrobial Chemotherapy 42, 199-209.
16. Iwen, P. C., Kelly, D. M., Linder, J., Hinrichs, S. H., Dominguez, E. A., Rupp, M. E. et al. (1997). Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrobial Agents and Chemotherapy 41, 494-5.
17. Tsakris, A., Pournaras, S. & Douboyas, J. (1997). Changes in antimicrobial resistance of enterococci isolated in Greece. Journal of Antimicrobial Chemotherapy 40, 735-7.
18. Appelbaum, P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Diseases 15, 77-83.
19. Felmingham, D., Robbins, M. J., Dencer, C., Nathwani, A. & Gruneberg, R. N. (1996). Antimicrobial susceptibility of community-acquired bacterial lower respiratory tract pathogens. Journal of Antimicrobial Chemotherapy 38, 747-51.
20. Schouten, M. A. & Hoogkamp-Korstanje, J. A. A. (1997). Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates. Journal of Antimicrobial Chemotherapy 40, 213-19.